San Diego Business Journal

Recent Stories

Allele Biotechnology Raises $11 Million

San Diego-based Allele Biotechnology & Pharmaceuticals Inc. has raised $11 million in equity funding, according to regulatory filings.

Tease photo

Mamma Chia Expands Leadership Team

Local beverage maker Mamma Chia is filling out its senior leadership team with four new hires focused on sales, marketing and operations.

NuVasive Reports Q3 Net Income of $21.1 Million

San Diego medical device maker NuVasive Inc. reported an increase in profit for its third quarter (ended Sept. 30) compared with the same period last year.

ResMed Posts Q1 Year-Over-Year Profit

San Diego medical device maker ResMed Inc. announced a boost to its profit in its first quarter (ended Sept. 30) compared to the same period last year.

Illumina Inc. to Collaborate with North Carolina-Based Q2 Solutions

Local science technology firm Illumina Inc. is collaborating with North Carolina-based Q2 Solutions to establish a framework for developing companion diagnostics, medical tests that are used “as a companion” to a drug to see if the drug is going to work for the patient.

CONNECT Hopes to House Diversity Accelerator in Proposed Downtown Convadium

San Diego business accelerator CONNECT is launching a diversity-focused startup incubator and accelerator program called CONNECT ALL.

Test Of Strengths - How Do S.D.’s Startup Ingredients Stand Up Against the Competition?

Much is made of how San Diego measures up to the nation’s top startup communities of San Francisco, Silicon Valley and New York City.

Tease photo

UC San Diego, Tata Trusts Establish Research Organization

The University of California, San Diego is collaborating with Indian philanthropic organization Tata Trusts to establish a research organization in India called Tata Institute for Active Genetics and Society.

Drugmaker aTyr Pharma's Leading Drug Gets Fast-Track Designation

San Diego drugmaker aTyr Pharma Inc. has received Fast Track designation from the U.S. Food and Drug Administration for its leading drug candidate Resolaris.

Tease photo

Salk Professor Awarded Grant for Work in Organ, Tissue Generation

Juan Carlos Izpisua Belmonte, a professor at the Salk Institute for Biological Studies, has been awarded a $2.5 million grant to continue his work in stem cell biology and regeneration.

More stories